5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing
A full human genome can now be sequenced for $1,000. That's still a little pricey for mass adoption, but Illumina and Pacific Biosciences could bring the cost down even further -- opening up the genomics floodgates.
Tax-Loss Selling: 1 Stock We'd Be Glad to Sell Right Now
If you own any of these, it might be a good time to cut your losses and move on.
Twitter's Favorite Biotech and Pharma Stocks
Consensus? We don't need no stinking consensus!
3 Beaten Down Stocks Ready to Bounce Back
Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.